MGWRX
Price
$60.62
Change
+$0.35 (+0.58%)
Updated
Sep 26 closing price
Net Assets
919.16M
RNPEX
Price
$71.60
Change
+$0.37 (+0.52%)
Updated
Sep 26 closing price
Net Assets
161.39B
Interact to see
Advertisement

MGWRX vs RNPEX

Header iconMGWRX vs RNPEX Comparison
Open Charts MGWRX vs RNPEXBanner chart's image
MFS Global Growth R2
Price$60.62
Change+$0.35 (+0.58%)
VolumeN/A
Net Assets919.16M
American Funds New Perspective R4
Price$71.60
Change+$0.37 (+0.52%)
VolumeN/A
Net Assets161.39B
MGWRX vs RNPEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MGWRX vs. RNPEX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGWRX is a Buy and RNPEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 161B vs. MGWRX (919M). RNPEX pays higher dividends than MGWRX: RNPEX (0.48) vs MGWRX (0.00). MGWRX was incepted earlier than RNPEX: MGWRX (22 years) vs RNPEX (23 years). MGWRX (1.57) is less costly to investors than RNPEX (0.76). RNPEX (24.00) and MGWRX (23.00) have comparable annual turnover. MGWRX has a lower initial minimum investment than RNPEX: MGWRX (0) vs RNPEX (250). RNPEX annual gain was more profitable for investors over the last year : 10.73 vs. MGWRX (-4.58). RNPEX return over 5 years is better than : 40.31 vs. MGWRX (22.71).
MGWRXRNPEXMGWRX / RNPEX
Total Expense Ratio1.470.76193%
Annual Report Gross Expense Ratio1.570.76207%
Fund Existence22 years23 years-
Gain YTD4.31917.55025%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets919M161B1%
Annual Yield % from dividends0.000.48-
Returns for 1 year-4.5810.73-43%
Returns for 3 years35.3761.3658%
Returns for 5 years22.7140.3156%
Returns for 10 years101.49110.4892%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX2.900.06
+2.11%
CytomX Therapeutics
SOLV71.370.91
+1.29%
Solventum Corp
EFSC58.840.22
+0.38%
Enterprise Financial Services Corp
WSBK9.560.03
+0.31%
Winchester Bancorp Inc
SPHL0.46-0.01
-2.28%
Springview Holdings Ltd